Abstract

Heterozygous mutations of the Hfe gene have been proposed as cofactors in the development and progression of nonalcoholic fatty liver disease (NAFLD). Homozygous Hfe deletion previously has been shown to lead to dysregulated hepatic lipid metabolism and accentuated liver injury in a dietary mouse model of NAFLD. We sought to establish whether heterozygous deletion of Hfe is sufficient to promote liver injury when mice are exposed to a high‐calorie diet (HCD). Eight‐week‐old wild‐type and Hfe +/− mice received 8 weeks of a control diet or HCD. Liver histology and pathways of lipid and iron metabolism were analyzed. Liver histology demonstrated that mice fed a HCD had increased NAFLD activity score (NAS), steatosis, and hepatocyte ballooning. However, liver injury was unaffected by Hfe genotype. Hepatic iron concentration (HIC) was increased in Hfe +/− mice of both dietary groups. HCD resulted in a hepcidin‐independent reduction in HIC. Hfe +/− mice demonstrated raised fasting serum glucose concentrations and HOMA‐IR score, despite unaltered serum adiponectin concentrations. Downstream regulators of hepatic de novo lipogenesis (pAKT, SREBP‐1, Fas, Scd1) and fatty acid oxidation (AdipoR2, Pparα, Cpt1) were largely unaffected by genotype. In summary, heterozygous Hfe gene deletion is associated with impaired iron and glucose metabolism. However, unlike homozygous Hfe deletion, heterozygous gene deletion did not affect lipid metabolism pathways or liver injury in this model.

Highlights

  • Nonalcoholic fatty liver disease (NAFLD) is increasingly common in the developed and developing world, affecting around 30% of many adult populations (Amarapurkar et al 2007; Vernon et al 2011)

  • Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society

  • Weight gain between 8 and 16 weeks of age was largely comparable between genotypes except for a small increase in WT high-calorie diet (HCD)-fed mice compared to their Hfe+/À counterparts (13.1 g vs 11.0 g, P = 0.04, Sidak’s multiple comparison test after two way ANOVA)

Read more

Summary

Introduction

Nonalcoholic fatty liver disease (NAFLD) is increasingly common in the developed and developing world, affecting around 30% of many adult populations (Amarapurkar et al 2007; Vernon et al 2011). Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. Effective treatment strategies to halt or reverse the natural history of NASH are lacking. Cofactors such as type II diabetes mellitus and iron overload have been implicated in NASH pathogenesis and represent readily treatable therapeutic targets (Dongiovanni et al 2011; Smith and Adams 2011). A greater understanding of the mechanisms by which such cofactors promote NASH disease progression is essential in order to develop effective treatments

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call